Development of Novel PRMT7 Inhibitors for the Treatment of Prostate Cancer.
Sign Up to like & getrecommendations! Published in 2025 at "Journal of medicinal chemistry"
DOI: 10.1021/acs.jmedchem.4c02978
Abstract: Prostate cancer (PCa) remains a prevalent malignancy in men and warrants novel and efficacious therapy. Protein arginine methyltransferase 7 (PRMT7) has been recently identified as a promising target for PCa treatment, however, the development of… read more here.
Keywords: prostate cancer; pca; prmt7 inhibitors; prmt7 ... See more keywords